Biospecimen & Biomarker Development Core
Biospecimen & Biomarker Development Core
批准号:
10410754
负责人:
Michael E Scheurer
金额:
$7.21万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-07-01 至 2027-06-30
关键词:
AdultAliquotBar CodesBiochemical MarkersBiologicalBiological AssayBiological MarkersBlood specimenCatalogsCharacteristicsChemopreventionCirrhosisClinicalClinical DataCollectionComprehensive Cancer CenterDNADataData AnalysesDatabasesDetectionDevelopmentDiabetes MellitusEnsureEquipment and supply inventoriesFutureGenetic MarkersGoalsHealthIndividualInvestigationKnowledgeLabelLinkLocationMalignant neoplasm of liverMedicineMetabolic dysfunctionMetabolic syndromeModelingObesityParticipantPatientsPlasmaPopulationPopulation SciencesPopulations at RiskPreparationPreventionPrevention strategyPrimary carcinoma of the liver cellsProceduresProcessProspective cohortProtocols documentationResearchResearch PersonnelResearch Project GrantsResource SharingResourcesRiskRisk FactorsSamplingSerumServicesShippingShipsSpecimen HandlingStandardizationTestingTexasTimeTranslational ResearchValidationWorkassay developmentbasebiobankbiomarker developmentbiomarker discoverybiomarker validationclinical research sitecohortcollegecostcost effectivenesscost estimateearly detection biomarkersethnic diversityfatty liver diseasefollow-upmetabolic-associated fatty liver diseasemortalitynovel markerphenotypic biomarkerprofessorprogramsprotective factorsracial and ethnic disparitiesracial diversityresearch studysuccesssynergism
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT—Biospecimen and Biomarker Development Core
The goal of the Program Project (PP) is to reduce the burden of hepatocellular carcinoma (HCC)-related mortality
through better understanding of contemporary risk factors (e.g., phenotypic, biochemical and genetic markers of
metabolic dysfunction) and preventive strategies (e.g., chemoprevention) of HCC related to metabolic
(dysfunction) associated fatty liver disease (MAFLD). To accomplish our goal, will need repeated collection,
shipping, processing and storage of thousands of blood samples that can be linked to demographic and clinical
data. These samples come from participants at one of eight clinical sites of the Texas HCC Consortium (THCCC)
prospective cohort. We propose 3 Projects, 2 shared resource Cores: Biospecimen and Biomarker
Development Core (BBDC) and Data and Analysis Core, and the Administrative Core.
The primary objectives of the BBDC are 1) to produce high-quality DNA, plasma, and serum for research
projects using standardized collection and processing procedures and 2) to spearhead biomarker assay
development and validation that supports the projects in the PP. The aims of the BBDC are to (1) receive,
process, and catalog all blood samples from patients participating in the THCCC; (2) Allocate and distribute
appropriate research samples to investigators and projects, and work with the biospecimen prioritization group
to prioritize samples; (3) Develop and conduct HCC biomarker assays and analyses as needed for Projects; and
(4) Maintain a biobank of well-annotated samples for future research.
The BBDC will serve as the central location to fully support these functions using previously developed standard
operating procedures. The BBDC will work closely with the Data and Analysis Core to maintain the sample
inventory database, produce labels with unique sample barcodes, and produce lists of patients with specific
characteristics, so the samples needed can be pulled for analysis. The BBDC will also provide up-to-date and
accurate data on sample availability and ensure that the Projects receive optimal samples for the proposed
analyses. Centralizing specimen processing and storage ensures consistent, high-quality sample preparation
that will help achieve the goals of the Projects and minimize costs. The BBDC will also ensure accurate
recordkeeping and guard patient protected health information. Importantly, the Core will provide expertise in
biomarker assay development and application, oversee sample preparation, profile additional targets and liaise
with institutional cores. Thus, the BBDC will provide indispensable services critical for the scientific and
operational success of the PP.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Sex and racial/ethnic differences in B-ALL genomics
-
批准号:10555358
-
项目类别:
-
资助金额:$15.5万
-
财政年份:2022
-
负责人:Michael E Scheurer
-
依托单位:
Biospecimen & Biomarker Development Core
-
批准号:10657446
-
项目类别:
-
资助金额:$7.07万
-
财政年份:2022
-
负责人:Michael E Scheurer
-
依托单位:
Ethnic disparities in methotrexate neurotoxicity among children and adolescents with ALL
-
批准号:10289496
-
项目类别:
-
资助金额:$18.71万
-
财政年份:2021
-
负责人:Michael E Scheurer
-
依托单位:
Admixture analysis of acute lymphoblastic leukemia in African American children: the ADMIRAL Study
-
批准号:10307680
-
项目类别:
-
资助金额:$1.16万
-
财政年份:2021
-
负责人:Michael E Scheurer
-
依托单位:
Ethnic disparities in methotrexate neurotoxicity among children and adolescents with ALL
-
批准号:10683990
-
项目类别:
-
资助金额:$8.23万
-
财政年份:2021
-
负责人:Michael E Scheurer
-
依托单位:
Ethnic disparities in methotrexate neurotoxicity among children and adolescents with ALL
-
批准号:10472703
-
项目类别:
-
资助金额:$7.45万
-
财政年份:2021
-
负责人:Michael E Scheurer
-
依托单位:
Investigator Development Core
-
批准号:10376062
-
项目类别:
-
资助金额:$23.8万
-
财政年份:2020
-
负责人:Michael E Scheurer
-
依托单位:
Administrative Core
-
批准号:10223897
-
项目类别:
-
资助金额:$9.12万
-
财政年份:2020
-
负责人:Michael E Scheurer
-
依托单位:
Administrative Core
-
批准号:10690830
-
项目类别:
-
资助金额:$12.5万
-
财政年份:2020
-
负责人:Michael E Scheurer
-
依托单位:
Administrative Core
-
批准号:10427341
-
项目类别:
-
资助金额:$9.24万
-
财政年份:2020
-
负责人:Michael E Scheurer
-
依托单位:
Admixture analysis of acute lymphoblastic leukemia in African American children: the ADMIRAL Study
-
批准号:10902170
-
项目类别:
-
资助金额:$63.5万
-
财政年份:2020
-
负责人:Michael E Scheurer
-
依托单位:
Administrative Core
-
批准号:10657473
-
项目类别:
-
资助金额:$9.55万
-
财政年份:2020
-
负责人:Michael E Scheurer
-
依托单位:
Pediatric HIV and Cancer Epidemiology
-
批准号:10223901
-
项目类别:
-
资助金额:$17.22万
-
财政年份:2020
-
负责人:Michael E Scheurer
-
依托单位:
Pediatric HIV and Cancer Epidemiology
-
批准号:10427345
-
项目类别:
-
资助金额:$17.52万
-
财政年份:2020
-
负责人:Michael E Scheurer
-
依托单位:
Pediatric HIV and Cancer Epidemiology
-
批准号:10657491
-
项目类别:
-
资助金额:$17.36万
-
财政年份:2020
-
负责人:Michael E Scheurer
-
依托单位:
2019 Scientific Annual Meeting for CLIC and CLIC+
-
批准号:9914518
-
项目类别:
-
资助金额:$1.2万
-
财政年份:2019
-
负责人:Michael E Scheurer
-
依托单位:
Nonhomologous end-joinging polymorphisms and HPV integration in cervical dysplasi
-
批准号:7791124
-
项目类别:
-
资助金额:$7.68万
-
财政年份:2009
-
负责人:Michael E Scheurer
-
依托单位:
Nonhomologous end-joinging polymorphisms and HPV integration in cervical dysplasi
-
批准号:7942056
-
项目类别:
-
资助金额:$7.68万
-
财政年份:2009
-
负责人:Michael E Scheurer
-
依托单位:
Infection and Inflammation in Adult Gliomas
-
批准号:7664430
-
项目类别:
-
资助金额:$13.54万
-
财政年份:2008
-
负责人:Michael E Scheurer
-
依托单位:
Infection and Inflammation in Adult Gliomas
-
批准号:7530650
-
项目类别:
-
资助金额:$13.54万
-
财政年份:2008
-
负责人:Michael E Scheurer
-
依托单位:
海外基金